Giovannelli e Associati advised Altheia Science on a capital increase of its corporate capital

Pubblicato da Giovannelli e Associati il 21/12/2018

Giovannelli e Associati advised Altheia Science, a biotech start-up incorporated to develop curative medicine for autoimmune diseases (multiple sclerosis and diabetes) on the capital increase of its corporate capital.

The team of Giovannelli e Associati comprised partner Gianvittorio Giroletti Angeli and associate Matilde Finucci.

TopLegal – 21.12.2018 – Altheia Science

Giovannelli e Associati has advised H-Farm

Giovannelli e Associati is advising Azelis on the acquisition of Deafarma S.r.l.﻿

Giovannelli e Associati advised Altheia Science on a capital increase of its corporate capital

Media correlati

Giovannelli e Associati with Nebula Aurea BidCo (White Bridge Investments III) on the voluntary all-inclusive offer on shares and warrants of Reevo

Giovannelli e Associati announces a round of promotions

Giovannelli e Associati awarded for the Venture Capital practice in 2022 in the context of the Class MF regional Awards, an initiative sponsored by Class Editori

Giovannelli e Associati is advising Azelis on the acquisition of Deafarma S.r.l.